Day 2 Highlights from the 20th International Myeloma Society Annual Meeting
September 30, 2023
View
Day 1 Highlights from the 20th International Myeloma Society Annual Meeting
September 29, 2023
MMRF Research Programs Expand Understanding of the Biology of Multiple Myeloma and Patient-Reported Outcomes in New Data Featured at the 20th IMS Annual Meeting
September 26, 2023
Answers to FAQs from our 8/25/23 webinar on High-Risk Multiple Myeloma
August 31, 2023
MMRF Statement on the FDA Approval of Talvey™ (talquetamab-tgvs) for the Treatment of Multiple Myeloma
August 10, 2023
Answers to FAQs from our 7/14/23 webinar on Minimal Residual Disease
July 18, 2023
Updates in Multiple Myeloma from ASCO 2023 for Healthcare Professionals
June 30, 2023
Answers to FAQs from our 6/20/23 webinar on Learn Your Labs
June 28, 2023
The latest myeloma treatment advances from ASCO 2023
June 8, 2023
Myeloma Investment Fund Invests in Nectin Therapeutics to Evaluate Nectin’s Anti-PVR Lead Drug Candidate as a Treatment for Multiple Myeloma
May 16, 2023
Answers to FAQs from our 5/5/23 webinar on Clinical Studies
May 15, 2023
Answers to FAQs from our 4/5/23 webinar on Multiple Myeloma Precursor Conditions
April 14, 2023
Knowledge is power. Sign up today and we’ll help you stay informed.
sign up
We value your privacy.
Get Your Free Toolkit